Owens & Minor EBITDA Margin 2010-2024 | OMI
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Owens & Minor (OMI) over the last 10 years. The current EBITDA margin for Owens & Minor as of March 31, 2024 is .
| Owens & Minor EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-03-31 | $10.42B | $0.40B | 3.79% |
| 2023-12-31 | $10.33B | $0.39B | 3.79% |
| 2023-09-30 | $10.23B | $0.28B | 2.75% |
| 2023-06-30 | $10.13B | $0.30B | 2.98% |
| 2023-03-31 | $10.07B | $0.37B | 3.64% |
| 2022-12-31 | $9.96B | $0.37B | 3.73% |
| 2022-09-30 | $9.87B | $0.44B | 4.42% |
| 2022-06-30 | $9.88B | $0.40B | 4.09% |
| 2022-03-31 | $9.87B | $0.38B | 3.80% |
| 2021-12-31 | $9.79B | $0.46B | 4.70% |
| 2021-09-30 | $9.68B | $0.49B | 5.10% |
| 2021-06-30 | $9.37B | $0.50B | 5.38% |
| 2021-03-31 | $8.69B | $0.43B | 4.97% |
| 2020-12-31 | $8.48B | $0.30B | 3.50% |
| 2020-09-30 | $8.31B | $0.22B | 2.66% |
| 2020-06-30 | $8.42B | $0.18B | 2.14% |
| 2020-03-31 | $8.98B | $0.18B | 1.99% |
| 2019-12-31 | $9.21B | $0.19B | 2.05% |
| 2019-09-30 | $9.14B | $0.22B | 2.44% |
| 2019-06-30 | $9.32B | $0.22B | 2.35% |
| 2019-03-31 | $9.40B | $0.19B | 2.04% |
| 2018-12-31 | $9.42B | $0.19B | 2.01% |
| 2018-09-30 | $9.69B | $0.12B | 1.26% |
| 2018-06-30 | $9.56B | $0.12B | 1.22% |
| 2018-03-31 | $9.36B | $0.14B | 1.53% |
| 2017-12-31 | $9.32B | $0.15B | 1.60% |
| 2017-09-30 | $9.30B | $0.20B | 2.16% |
| 2017-06-30 | $9.38B | $0.22B | 2.37% |
| 2017-03-31 | $9.60B | $0.24B | 2.53% |
| 2016-12-31 | $9.72B | $0.25B | 2.61% |
| 2016-09-30 | $9.84B | $0.26B | 2.68% |
| 2016-06-30 | $9.90B | $0.27B | 2.69% |
| 2016-03-31 | $9.84B | $0.27B | 2.69% |
| 2015-12-31 | $9.77B | $0.27B | 2.72% |
| 2015-09-30 | $9.78B | $0.26B | 2.63% |
| 2015-06-30 | $9.69B | $0.24B | 2.45% |
| 2015-03-31 | $9.58B | $0.22B | 2.33% |
| 2014-12-31 | $9.44B | $0.22B | 2.36% |
| 2014-09-30 | $9.27B | $0.22B | 2.42% |
| 2014-06-30 | $9.15B | $0.24B | 2.59% |
| 2014-03-31 | $9.08B | $0.25B | 2.73% |
| 2013-12-31 | $9.07B | $0.25B | 2.74% |
| 2013-09-30 | $9.04B | $0.24B | 2.68% |
| 2013-06-30 | $8.95B | $0.24B | 2.65% |
| 2013-03-31 | $8.90B | $0.24B | 2.66% |
| 2012-12-31 | $8.87B | $0.24B | 2.66% |
| 2012-09-30 | $8.78B | $0.23B | 2.63% |
| 2012-06-30 | $8.78B | $0.24B | 2.75% |
| 2012-03-31 | $8.72B | $0.24B | 2.73% |
| 2011-12-31 | $8.63B | $0.24B | 2.76% |
| 2011-09-30 | $8.50B | $0.23B | 2.74% |
| 2011-06-30 | $8.39B | $0.23B | 2.73% |
| 2011-03-31 | $8.28B | $0.23B | 2.77% |
| 2010-12-31 | $8.12B | $0.23B | 2.77% |
| 2010-09-30 | $8.09B | $0.24B | 2.97% |
| 2010-06-30 | $8.07B | $0.24B | 2.98% |
| 2010-03-31 | $8.06B | $0.24B | 2.93% |
| 2009-12-31 | $8.04B | $0.23B | 2.81% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.013B | $10.334B |
| Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $179.530B | 23.51 |
| Stryker (SYK) | United States | $127.352B | 30.50 |
| Boston Scientific (BSX) | United States | $112.306B | 35.77 |
| Medtronic (MDT) | Ireland | $99.209B | 14.85 |
| EssilorLuxottica (ESLOY) | France | $98.424B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.079B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.036B | 27.77 |
| ResMed (RMD) | United States | $27.817B | 26.12 |
| Terumo (TRUMY) | Japan | $24.149B | 34.10 |
| Koninklijke Philips (PHG) | Netherlands | $22.914B | 18.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.863B | 13.97 |
| Baxter (BAX) | United States | $16.740B | 11.90 |
| Insulet (PODD) | United States | $13.811B | 61.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.789B | 0.00 |
| Demant (WILYY) | Denmark | $9.175B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.686B | 36.15 |
| Bio-Rad Laboratories (BIO) | United States | $7.632B | 24.96 |
| Lantheus Holdings (LNTH) | United States | $5.441B | 13.56 |
| Haemonetics (HAE) | United States | $4.232B | 20.87 |
| GN Store Nord (GNNDY) | Denmark | $4.129B | 23.18 |
| Perrigo (PRGO) | Ireland | $3.543B | 10.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.408B | 16.22 |
| Neogen (NEOG) | United States | $3.277B | 31.52 |
| ICU Medical (ICUI) | United States | $2.864B | 25.27 |
| TG Therapeutics (TGTX) | United States | $2.830B | 79.61 |
| Envista Holdings (NVST) | United States | $2.808B | 11.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.387B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.363B | 46.25 |
| QuidelOrtho (QDEL) | United States | $2.100B | 11.66 |
| LeMaitre Vascular (LMAT) | United States | $1.822B | 53.41 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.723B | 0.00 |
| Warby Parker (WRBY) | United States | $1.589B | 0.00 |
| InMode (INMD) | Israel | $1.462B | 7.77 |
| AdaptHealth (AHCO) | United States | $1.317B | 9.79 |
| Verano Holdings (VRNOF) | United States | $1.228B | 0.00 |
| AtriCure (ATRC) | United States | $1.065B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.980B | 31.20 |
| BioLife Solutions (BLFS) | United States | $0.932B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.676B | 14.40 |
| PetIQ (PETQ) | United States | $0.672B | 21.72 |
| Evolus (EOLS) | United States | $0.667B | 0.00 |
| Surmodics (SRDX) | United States | $0.598B | 37.47 |
| VAREX IMAGING (VREX) | United States | $0.596B | 14.02 |
| Valneva SE (VALN) | France | $0.505B | 0.00 |
| ZimVie (ZIMV) | United States | $0.495B | 42.19 |
| Quanterix (QTRX) | United States | $0.487B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.477B | 0.00 |
| Biote (BTMD) | United States | $0.475B | 10.93 |
| Jin Medical (ZJYL) | China | $0.398B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.376B | 0.00 |
| Cerus (CERS) | United States | $0.314B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.302B | 9.71 |
| Zynex (ZYXI) | United States | $0.288B | 39.44 |
| MacroGenics (MGNX) | United States | $0.257B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.239B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.233B | 14.69 |
| Omeros (OMER) | United States | $0.223B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.213B | 0.00 |
| High Tide (HITI) | Canada | $0.171B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.155B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.155B | 21.96 |
| Capricor Therapeutics (CAPR) | United States | $0.151B | 0.00 |
| Veru (VERU) | United States | $0.140B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.137B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.133B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.105B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 10.19 |
| Brainsway (BWAY) | Israel | $0.099B | 0.00 |
| InterCure (INCR) | Israel | $0.093B | 15.77 |
| Cellectar Biosciences (CLRB) | United States | $0.085B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.068B | 4.43 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.060B | 0.00 |
| Safety Shot (SHOT) | United States | $0.060B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Bright Green (BGXX) | United States | $0.050B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.52 |
| ImmuCell (ICCC) | United States | $0.032B | 0.00 |
| Exagen (XGN) | United States | $0.031B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Agape ATP (ATPC) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |